AXA Investment Managers’s Takeda Pharmaceutical TAK Stock Holding History

AXA Investment Managers’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$42K	Buy	+2,868	New	+$42.6K	﹤0.01%	1159

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

AXA Investment Managers's TAK Position: Q3 2025 in Review

AXA Investment Managers opened a new position in Takeda Pharmaceutical (TAK) in Q3 2025: 2,868 shares worth $42K. The stake represents ﹤0.01% of the portfolio and ranks #1159 among its holdings.

329 funds tracked by Wall St. Rank hold TAK as of Q3 2025.

AXA Investment Managers held 2,868 shares of Takeda Pharmaceutical worth $42K as of Q3 2025.
Takeda Pharmaceutical was a new AXA Investment Managers position in Q3 2025.
Takeda Pharmaceutical made up ﹤0.01% of AXA Investment Managers's portfolio in Q3 2025, its #1159 holding.
329 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2025.

Based on AXA Investment Managers's 13F filing for Q3 2025, filed 14 Nov 2025.